Intracranial Artery Stenosis Clinical Trials

6 recruitingLast updated: May 13, 2026

There are 6 actively recruiting intracranial artery stenosis clinical trials across 1 country. Studies span Not Applicable, Phase 2, Phase 3, Phase 4. Top locations include Nanjing, Jiangsu, China, Liaocheng, Shandong, China, Harbin, Heilongjiang, China. Updated daily from ClinicalTrials.gov.


Intracranial Artery Stenosis Trials at a Glance

6 actively recruiting trials for intracranial artery stenosis are listed on ClinicalTrialsFinder across 6 cities. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Nanjing, Liaocheng, and Harbin. Lead sponsors running intracranial artery stenosis studies include Nanjing First Hospital, Nanjing Medical University, Beijing Tiantan Hospital, and Fuzhou General Hospital of Nanjing Command, PLA and clinical medical college of Fujian medical university.

Browse intracranial artery stenosis trials by phase

Treatments under study

About Intracranial Artery Stenosis Clinical Trials

Looking for clinical trials for Intracranial Artery Stenosis? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Intracranial Artery Stenosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Intracranial Artery Stenosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Not Applicable

Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome

Intracranial Artery Stenosis
Nanjing First Hospital, Nanjing Medical University180 enrolled2 locationsNCT05397405
Recruiting
Phase 4

PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis

Atherosclerotic PlaqueIntracranial AtherosclerosisIntracranial Artery Stenosis
Peking Union Medical College Hospital300 enrolled19 locationsNCT06902740
Recruiting

Gut Microbiota and Prognostic Outcomes in Intracranial Arterial Stenosis Patients(GROW-ICAS)

Intracranial Artery Stenosis
Nanjing First Hospital, Nanjing Medical University500 enrolled1 locationNCT07085299
Recruiting
Not Applicable

A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China

Intracranial ArteriosclerosisStenosis ArteryDrug-Eluting Stents+1 more
Sino Medical Sciences Technology Inc.1,000 enrolled5 locationsNCT05692882
Recruiting
Phase 3

Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4)

TIAIschemic Stroke, Acutesymptomatic intracranial artery stenosis
Beijing Tiantan Hospital4,674 enrolled5 locationsNCT06319846
Recruiting
Phase 2

Angioplasty and Stenting versus medical treatment in patients with symptomatic intracranial artery stenosis: a randomized controlled trial and a preference cohort

symptomatic intracranial artery stenosis
Fuzhou General Hospital of Nanjing Command, PLA and clinical medical college of Fujian medical university198 enrolled1 locationACTRN12615000759594